Annual Symposium
Each Fall the Institute for Drug Discovery presents a symposium which provides exceptional speakers from around the country, while also showcasing faculty research and providing an opportunity for collaborations to begin.
2024 - 9th Annual Symposium
Friday, September 20, 2024 in the Purdue Memorial Union
Keynote Speakers included:
Guoxin Zhu (Eli Lilly) - "Setting a course for biopharmaceutical innovation in the new era"
Anna Mapp (U. Michigan) - "Lessons from nature: how to drug transcription factors"
Brian Shoichet (UCSF) - "Ligand discovery and optimization in a vast chemical space"
2023 - 8th Annual Symposium
Friday, October 6, 2023 in the Stewart Center
Keynote Speakers included:
Lieping Chen (Yale) - "Targeting immunotherapy to the tumor microenvironment"
Bryan Roth (U. North Carolina) - "Illuminating the receptors of perception"
Daniel Nomura (Berkeley) - "Reimagining druggability using chemoproteomic platforms"
2022 - 7th Annual Symposium
Friday, September 30, 2022 in the Stewart Center
Keynote Speakers included:
Brian Blagg (Notre Dame) - "From pan to selective inhibition of Hsp90: new therapies for cancer, glaucoma, and CNS disorders"
Gunda Georg (U. Minnesota) - "Retinoic acid receptor antagonist for non-hormonal male contraception"
Phil Low (Purdue) - "A new generation of targeted therapies"
2020 - 2021
In order to ensure the safety of our symposium attendees, the 2020 and 2021 annual symposiums were cancelled due to the SARS-CoV-2 pandemic.
2019 - 6th Annual Symposium
Monday, October 14 in the Buchanan Club at Ross-Ade Stadium
Keynote Speakers included:
Dennis Liotta (Emory) - "Novel therapeutics for treating viral diseases, cancers, and inflammatory diseases"
Nathanael Gray (Harvard) - "Small molecule directed protein degradation - a new paradigm for drug discovery"
Jun Liu (Johns Hopkins) - "Discovery of new drugs from known drugs and natural products"
2018 - 5th Annual Symposium
Friday, September 28 in Stewart Center
Keynote Speakers included:
Min Li (GlaxoSmithKline)- "Neuroscience therapeutics through the 2020 lens"
Philip Cole (Harvard) - "AKTivation mechanisms"
Shaomeng Wang (U. Michigan) - "Targeting protein degradation for new therapeutics"
2017 - 4th Annual Symposium
Wednesday, October 11 in the North Ballroom of the Purdue Memorial Union
Keynote Speakers included:
Richard DiMarchi (Indiana University)
Michael Jensen (Seattle Children's Hospital)
2016 - 3rd Annual Symposium
Friday, September 30 in the Buchanan Club at Ross-Ade Stadium
Keynote Speakers included:
Richard Silverman (Northwestern)
Nicholas Meanwell (Bristol-Myeres Squibb)
Daniel Powell (U. Pennsylvania)
2015 - 2nd Annual Symposium
Friday, September 18 in the Burton D. Morgan Center for Entrepreneurship
Keynote Speakers included:
Ben Shen (Scripps) - "Microbial genomics: new opportunities for natural product biosynthesis, engineering, and drug discovery"
Liang Xu (Kansus University) - "Undruggable: new frontiers in precision medicine"
Susan Mooberry (UT San Antonio) - "Semi-synthesis from the bat flower: source of next generation microtubule stabilizers"
Jesse Rinehart (Yale) - "Reengineering protein phosphorylation to target cancer"
2014 - 1st Annual Symposium
Thursday, September 4 in the Burton D. Morgan Center for Entrepreneurship
Keynote Speakers included:
Paul Hergenrother (U. Illinois at Urbana-Champaign) - "Procaspase-3 activation as an anticancer strategy. From compound discovery to human clinical trial"
Phil Hipskind (Eli Lilly) - "Hedgehog pathway inhibitors for the treatment of cancer"
Dong Wang (U. Nebraska) - "Glucocorticoid prodrug development for inflammatory disease"
Chris Hulme (U. Arizona) - "Expediting drug discovery in academia through enabling chemistry"